Skip to search formSkip to main contentSkip to account menu

biomaterial incompatibility

Known as: bioincompatibility 
National Institutes of Health

Related topics

Related topics

1 relation
biocompatibility

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Preservation of residual renal function in dialysis patients.
The number of patients with end-stage renal disease continues to increase worldwide, but the 5-year survival probability for… 
2008
2008
Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.
The degree of biocompatibility of biomaterials can be evaluated using various assay systems detecting activation of the blood… 
Review
2005
Review
2005
Acute vs chronic volume overload on arterial stiffness in haemodialysis patients
Volume overload is a cardinal feature of end-stage renal disease (ESRD) patients. Acute volume overload, as represented by… 
2003
2003
Induction of Cytokines and Adhesion Molecules in Stable Hemodialysis Patients: Is There an Effect of Membrane Material?
Background/Aims: The aim of this study was to examine the effects of a biocompatible and a nonbiocompatible hemodialysis membrane… 
2001
2001
Glucose Degradation Products in Peritoneal Dialysis Fluids: How they can be Avoided
♦ Objectives A patient on peritoneal dialysis (PD) uses 3 – 7 tons of PD fluid every year. The result is considerable stress on… 
Review
1998
Review
1998
Cytokines and bioincompatibility.
Review
1998
Review
1998
Haemodialysis-related bioincompatibility: fundamental aspects and clinical relevance.
1996
1996
Cytokine production during hemodialysis: effects of dialytic membrane and complement activation.
Interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) are closely associated with acute and chronic… 
1996
1996
Cell-associated adhesion molecules as early markers of bioincompatibility.
BACKGROUND Transient nature of adhesive interactions occurring during cell margination is mainly dependent on expression of… 
Review
1995
Review
1995
Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications?
Studies have shown differences between host defence dysfunctions in patients with end-stage renal disease (ESRD), patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)